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Abstract-Modernizing our health care system will lead to im-
provements in medical research.  Health informatics will allow 
medical researchers to determine the effectiveness of a particular 
treatment for a given population or to discover the harmful side-
effects of a drug.  While some of this research will occur in the 
private sector, public investment in this area will also be impor-
tant.  This report finds that both the United States and the United 
Kingdom commit roughly the same percentage of total public 
medical research funds to health informatics.  However, the 
United Kingdom has a much richer data set of patient data avail-
able for research.  To benefit from the full potential of health 
informatics, the United States should develop the capability to 
share medical data for authorized research in a timely and effi-
cient manner. 
I.  INTRODUCTION 
Many developed countries have announced initiatives to 
modernize their health care systems with investments in health 
information technology (IT).  The goal of these initiatives is to 
use technology to improve the health care system by reducing 
costs, increasing patient safety and improving quality of care.  
Improving health care is a common goal for these countries, 
but there are wide disparities in the success with which nations 
have pursued this goal [1]. 
In particular, countries such as the United States have 
lagged behind some European nations in the adoption of 
health IT, such as electronic health records.  Interoperable 
electronic health records are a prerequisite for a modern health 
care system and the key to delivering a number of benefits to 
health care patients and payers.  For example, the compute-
rized decision support systems used in hospitals provide pa-
tients the most benefit when they use a complete and accurate 
set of patient data.  These systems can help ensure a return to 
the core principle of evidence-based medicine—that patients 
and doctors have the best evidence available when making a 
decision about treatment. 
While much attention has been paid to the degree to which 
nations have made progress with investment in health IT, less 
attention has been paid to the level of investment in health IT 
research.  Yet evidence-based medicine relies on high quality 
medical research.  Moreover, as we enter an increasingly digi-
tal world, the amount of health data that will be available to 
medical researchers will be increasing substantially.  While 
past medical researchers had only a few limited data points 
recorded on paper on which to base their hypotheses, in the 
future researchers will have massive online databases contain-
ing terabytes of data for their analysis. 
Some of the major benefits from modernizing our health 
care system are expected to come from the improvements in 
medical research that it will enable.  For example, medical 
researchers will be able to use rapid-learning health networks 
to determine the effectiveness of a particular treatment for a 
certain population or to discover harmful side-effects of a 
drug.  While some of this research will occur in the private 
sector, for example through private pharmaceutical research, 
public investment in this area will also be important. 
Already a variety of projects offer a glimpse into the possi-
bilities that IT will allow for future medical research.  But 
achieving this vision will require substantial leadership and 
effort on the part of nations to overcome the technical and 
social hurdles ahead. 
Some of the questions this paper will look at are as follows: 
How are the United States and the United Kingdom integrat-
ing health informatics into their overall commitment to im-
proving health care?  To what degree are these nations invest-
ing in the technology that will provide the platform for this 
research?  How have national research institutes addressed 
medical research as not simply a domestic issue, but as an 
international challenge that must be answered with interna-
tional partnerships? 
This paper will look at the degree to which the United 
States and the United Kingdom are pursuing data intensive, 
IT-based medical research.  The paper will review public pro-
grams and efforts in this field in each country.  In addition, the 
report will quantify public investment in these programs—
both past investment and projected investments.  Finally, the 
report will make a qualitative assessment of the effectiveness 
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of policies and initiatives in each country to advance this type 
of research. 
II.  BACKGROUND 
A. Informatics in Health Care 
Health care is becoming an increasingly data-intensive field 
as doctors and researchers generate gigabytes of medical data 
on patients and their illnesses.  While a patient visiting the 
doctor 20 years ago may have only generated a few data 
points—basic information such as weight, blood pressure, and 
symptoms—a medical encounter today may leave a long trail 
of digital data from the use of high-definition medical imaging 
to implantable or wearable medical devices such as heart mon-
itors.  More importantly, as doctors and hospitals transition 
away from paper medical records, this data is increasingly 
being collected and made available in an electronic format.  
The availability of large data sets of digital medical informa-
tion has made possible the use of informatics to improve 
health care and medical research.  Often referred to as “in sili-
co” research, informatics offers a new pathway for medical 
discovery and investigation.  Informatics focuses on develop-
ing new and better ways of using technology to process infor-
mation.  Today, informatics is being applied at every stage of 
health care from basic research to care delivery and includes 
many specializations such as bioinformatics, medical infor-
matics, and biomedical informatics. 
The field of bioinformatics has exploded within the past 
decade to keep pace with advancements in molecular biology 
and genomics research.  Researchers use bioinformatics to 
gain a better understanding of complex biological processes 
by, for example, analyzing DNA sequences or modeling pro-
tein structures.  The most famous example of this is the Hu-
man Genome Project which relied on informatics to correctly 
analyze and sequence the 3 billion chemical base pairs that 
make up human DNA [1].  Much progress in basic research 
has been made possible by advancements in information tech-
nology, including the computing power, storage technology 
and software algorithms needed to collect, store and analyze 
the large data sets involved in genetic research. 
Informatics has also had a major impact on the field of sys-
tems biology.  Systems biology uses computer modeling and 
mathematical simulations to predict how complex biological 
systems will behave.  For example, researchers have created 
models to simulate tumor growths.  Through the application of 
computer models researchers can gain a better and more com-
prehensive understanding of how diseases affect an entire bio-
logical system in addition to the effects on individual compo-
nents [2].   
Medical informatics, or clinical informatics, focuses on us-
ing information processing to improve health care delivery.  It 
covers various applications including using information tech-
nology within the clinical setting for medical billing, patient 
and resource scheduling, and patient care.  An example of 
medical informatics is the use of clinical decision support sys-
tems (CDSS) which provide feedback and instruction to health 
care workers at the point of care.  Such a system may, for ex-
ample, provide warnings of potential drug interactions to a 
prescribing doctor based on a patient’s existing medical histo-
ry and known allergies.  By integrating patient information 
with clinical guidelines, health care providers can help reduce 
medical errors.  Adverse drug events alone account for an es-
timated 19 percent of injuries in hospitalized patients in the 
United States and cost hospitals over $2 billion per year, ex-
cluding medical malpractice expenses [5]. 
Biomedical informatics is a unique discipline that bridges 
multiple fields including medical research, clinical care and 
informatics.  At its core, the objective of biomedical informat-
ics is to develop new tools and technology to better collect, 
display, retrieve and analyze biomedical data.  Such research 
can lead to new treatments, diagnostic tests, personalized med-
icine and better understanding of illnesses. 
B. Benefits of Health Informatics 
Bringing together large data sets of medical data and tools 
to analyze this data offers the potential to expand the research 
capabilities of doctors and scientists.  Medical researchers can 
use this vast source of biological and clinical data to discover 
new treatments and better understand illnesses.  Pharmaceuti-
cal companies can use the biomedical data to create drugs tar-
geted at specific populations.  Health care providers can use 
the data to better inform their treatments and diagnoses. 
Applying informatics to health care creates the possibility 
of enabling “rapid learning” health applications to aid in bio-
medical research, effectiveness research and drug safety stu-
dies [7].  For example, using this technology, the side-effects 
from drugs newly introduced to the market can be monitored 
in real-time, and problems, such as those found with the re-
cently withdrawn prescription drug Vioxx, can be identified 
more quickly.  Moreover, the risks and benefits of drugs can 
be studied for specific populations yielding more effective and 
safer treatment regimens for patients. 
As Reference [7] has noted, using rapid learning techniques 
can not only improve patient safety, it can also lead to sub-
stantial improvements in the quality and cost of care.  By turn-
ing all of this raw digital data into knowledge, these rapid 
learning health networks can enable doctors to better practice 
evidence-based medicine.  Evidence-based medicine is the use 
of treatments judged to be the best practice for a certain popu-
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lation on the basis of scientific evidence of expected benefits 
and risks.  Cost savings in health care is a growing priority in 
both the United States and the United Kingdom as their health 
care costs continue to rise and populations get older.  By using 
rapid learning networks, health care workers can identify not 
only the most effective treatments, but also the most cost-
effective treatments given a patient’s specific medical profile. 
C. Building the Digital Platform for Medical Research 
Achieving this vision of an intelligent and fully-connected 
health care research infrastructure has not yet been realized.  
While various pilot projects have shown success and have 
demonstrated the potential benefits that can emerge from a 
ubiquitous deployment of informatics in health research, many 
technical obstacles still need to be overcome.  These obstacles 
include making data accessible, connecting existing data 
sources, and building better tools to analyze medical data and 
draw meaningful conclusions. 
Much medical research data is not accessible electronically.  
For example, one challenge for the United States and the Unit-
ed Kingdom are the low rates of adoption of electronic health 
records among primary care providers and in hospitals.  Elec-
tronic health records provide a complete medical history for a 
patient, including a full account of the patient’s illnesses, 
treatments, laboratory results, medication history and known 
allergies.  Among primary care providers, approximately one 
quarter use an EHR system in the United States and 89 percent 
use them in the United Kingdom.  At hospitals, the rate of use 
is much lower with only about 10 percent or fewer of the hos-
pitals in the United States and the United Kingdom having 
adopted EHR systems [19].  Achieving the widespread use of 
electronic health records is a necessary requirement for creat-
ing the underlying data sets needed for biomedical informatics 
research.  Access to the electronic health records of large pop-
ulations will help researchers apply informatics to various 
problems including clinical trial research, comparative effec-
tiveness studies, and drug safety monitoring. 
However, collecting medical data in electronic format is on-
ly the first step.  Interoperability poses a substantial challenge 
for biomedical research.  The vast amount of electronic medi-
cal data cannot fully be utilized by researchers because the 
data resides in different databases.  Even when the organiza-
tions that collect and distribute biomedical data are willing to 
share data, incompatible data formats or data interfaces can 
create challenges for analyzing data across multiple data sets.  
As a result, researchers wishing to use multiple data sets must 
devote significant resources simply to managing the differenc-
es between the data and, as a result, have fewer resources 
available for working with the data [6].   
For many years individuals in the research community have 
called for increased coordination and interoperability among 
data repositories to advance the use of informatics in health 
care.  They have proposed various options to address interope-
rability although, to date, no proposal has achieved universal 
acceptance [6, 7].  One interim solution has been the devel-
opment of online communities to share programming code to 
reduce the burden of working with diverse data sets.  The most 
notable, Bio*, is a collection of open-source biomedical in-
formatics projects that provide re-usable code for researchers 
to use that automate common computing tasks.  For example, 
the project includes modular programming code to manipulate 
DNA sequences or combine data sets from different data 
sources [6]. 
III.  NATIONAL PRIORITIES IN HEALTH INFORMATICS 
Both the United States and the United Kingdom have made 
significant investments in health informatics.  Measuring the 
level of public investment in health informatics at the national 
level is an imprecise science as many forms of medical re-
search involve an IT or informatics component.  In addition, 
funding for this research comes from various government 
sources.  However, one trend is clear: the proportion of medi-
cal research that relies on mathematical modeling or data in-
tensive, high-speed computing is on the rise. 
This section will enumerate the current investments being 
made by the national governments in the United States and the 
United Kingdom in research to develop IT tools for medical 
research.  Although the distinction is not always perfect, this 
section makes an effort to not highlight investments in medical 
research that simply uses IT, but rather to focus on those that 
rely on IT as the principal method for investigation. 
A. United States 
In the United States, the public funding for biomedical in-
formatics research has come principally through the U.S. De-
partment of Health and Human Services (HHS).  Within HHS, 
the primary funding agency is the National Institutes of Health 
(NIH), although additional funds come from the Centers for 
Disease Control and Prevention (CDC), the Agency for Health 
Research and Quality (AHRQ), and the Food and Drug Ad-
ministration (FDA).  Some additional financial support for 
biomedical informatics research may come from the National 
Science Foundation, although its intended mission is to fund 
science and technology research outside of medicine. 
NIH invests $30.5 billion annually in medical research.  The 
growing importance of information technology at NIH can be 
seen in the increasing level of investment NIH makes in IT-
related grants.  Funding for “Network and Information Tech-
nology R&D”, while not strictly funding for biomedical in-
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formatics, has shown a significant increase over the past 5 
years.  Whereas funding for FY 2005 totaled only $509 mil-
lion, the NIH estimates funding will reach $950 million in FY 
2010 [11].  The NIH also runs the High Performance Compu-
ting and Informatics Office within its Center for Information 
Technology.  The mission of this office is to provide the high 
performance computing resources and tools needed to allow 
the NIH scientific community to conduct its biomedical re-
search.  This office provides the software applications needed 
by researchers for bioinformatics, structural biology and pro-
teomics. 
Investment in biomedical informatics research at NIH 
comes principally from three sources of funding: the NIH Na-
tional Centers for Biomedical Computing (NCBC), the Na-
tional Cancer Institute Center for Bioinformatics (NCICB), 
and the National Center for Biotechnology Information 
(NCBI). 
The NCBC is an important strategic investment for NIH.  In 
2004, the NIH created a Roadmap for Medical Research to 
“address roadblocks to research and to transform the way 
biomedical research is conducted by overcoming specific hur-
dles or filling defined knowledge gaps” [12].  One objective of 
creating the Roadmap was to ensure that these programs 
would get funded since many of these initiatives might other-
wise fall outside the domain of existing centers within NIH or 
appear too risky.  The Roadmap was initially funded by a 1 
percent contribution from each center within NIH, but since 
2006 has been funded directly by Congress. 
One of the three principal themes of the Roadmap is to de-
velop a better toolbox for medical research that will enable 
scientists to better understand diseases at the molecular level.  
A key initiative in this theme is to have a Bioinformatics and 
Computational Biology initiative that will allow researchers to 
share, analyze, integrate and visualize large data sets.   
The major project within the Bioinformatics and Computa-
tional Biology initiative is the NCBC.  NIH created the NCBC 
through a two-stage funding process with the goal of creating 
specialized biomedical computing centers at educational insti-
tutions in the United States.  As described by NIH, the NCBC 
is “devoted to all facets of biomedical computing, from basic 
research in computational science to providing the tools and 
resources that biomedical and behavioral researchers need to 
do their work” [12].  In addition, the NCBC serves as a center 
of learning to educate and train additional biomedical infor-
matics researchers.  In FY 2004 NIH devoted between $14 and 
$17 million to fund the NCBC, and in FY 2005 NIH commit-
ted $12-14 million.  A total of seven grants have been awarded 
to different institutions [12].  
The second major biomedical informatics program at NIH 
is NCICB.  NCICB is a division of the National Cancer Insti-
tute, an organization within NIH.  Created in 2001, NCICB 
has been a pioneer in advancing the use and development of 
biomedical informatics infrastructure, tools, and data to im-
prove medical research.  In 2006, NCICB was reorganized 
into the Center for Biomedical Informatics and Information 
Technology (CBIIT).  Funding for the Center has increased 
steadily over the years from $71.7 million in FY 2005 to 
$101.2 million in FY 2009, an increase of approximately 40 
percent over 4 years [4]. 
The major investment in this area by NCI has been for the 
cancer Biomedical Informatics Grid (caBIG), a program tar-
geted at harnessing bioinformatics to advance cancer research.  
While caBIG has been funded by the NCI, it is a collaborative 
program involving over 80 organizations.  Described as “an 
Internet for cancer research”, the caBIG project is intended to 
make the vast amount of medical data being generated by pa-
tients available, accessible and usable to medical researchers 
by connecting cancer centers, cancer researchers, and partici-
pants involved in clinical trials [2].   
As explained in Reference [2] by Dr. Kenneth Beutow, the 
director of the caBIG program, the purpose of caBIG is as 
follows: “Personalized medicine is all about information. But 
for information to be useful, it has to be accessible. What we 
are doing with caBIG is facilitating accessibility through inte-
roperability, essentially creating an environment where infor-
mation can be exchanged, integrated, and acted upon.”  In 
addition, efforts from caBIG include developing software ap-
plications to manage clinical trials and share research data.  
caBIG has also worked to establish a common lexicon for data 
exchange and develop best practices for the use of electronic 
health records. 
caBIG has already yielded important applications for medi-
cal research.  For example, one tool developed by caBIG is the 
Biological Pathway Exchange which is used to model the sig-
nal transduction pathways, or biological pathways, used for 
communication between and within cells.  These communica-
tion pathways help determine cell behavior, such as whether 
they thrive or perish and if they spreading to other parts of the 
body.  Such research is especially useful to scientists studying 
proteomics as it helps them to better understand how proteins 
interact with each other [2].  The success of the caBIG pro-
gram has led to the development of the BIG Health Consor-
tium, a public-private partnership that seeks to bring together 
previously unconnected sectors of the life sciences and health 
care using the caBIG model to pursue research in personalized 
medicine. 
Between 2004 and 2006, NCICB (now CBIIT) provided 
$20 million annually in funding to caBIG during its pilot 
phase [3].  The pilot phase concluded in 2007 and funding for 
the enterprise phase of caBIG has increased.  For FY 2008 
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funding increased to $45.8 million and estimated funding for 
FY 2009 is $43.1 million [4].  
The 2010 Professional Judgment Budget Request from the 
National Cancer Institute (NCI) shows the importance that the 
National Health Institutes places on an increase in investment 
in bioinformatics.  The purpose of the budget request is to 
describe “what a financial infusion could make possible and 
how NCI would spend those monies” [2].  For 2010, the NCI 
has proposed an increase of $2.1 billion in total funding, a 
substantial increase over its 2009 budget of approximately 
$5.0 billion.  Of these funds, NCI would direct a substantial 
portion of the increased investment into bioinformatics includ-
ing $40 million to increase research in systems biology, $45 
million for increasing biomedical computing capabilities and 
$100 million to expand caBIG and help support the BIG 
Health Consortium.  In addition, NCI proposed a substantial 
investment in other research priorities with a heavy bioinfor-
matics component such as committing $200 million to ex-
panding The Cancer Genome Atlas (TCGA).  The Cancer Ge-
nome Atlas is a collaborative effort with the National Human 
Genome Research Institute to collect large data sets on the 
genetic makeup of various forms of cancer and develop the 
technology needed to sequence and analyze DNA from tu-
mors.  With the additional funds, NCI predicts it could record 
the genome of up to six tumor types per year. 
The third significant source of investment in bioinformatics 
from NIH comes from the National Center for Biotechnology 
Information (NCBI).  NCBI is a division of the National Li-
brary of Medicine (NLM), an organization within NIH.  NCBI 
is a significant program within NLM, accounting for $73.5 
million in the FY 2006 budget out of a total NLM budget of 
$329.5 million.  In addition, NLM supports biomedical infor-
matics through its extramural programs division.  This divi-
sion awards grants to support basic and applied research in 
biomedical informatics, training and education for informati-
cians, resources for medical libraries, and scientific confe-
rences.  In FY 2006 the budget for extramural programs to-
taled $69.2 million. 
Congress established NCBI in 1988 to create a national re-
pository for molecular biology information.  The importance 
of the NCBI mission has expanded with the flood of genomic 
data and the increasing reliance on bioinformatics by medical 
researchers.  NCBI supports its mission by developing and 
supporting the information systems and software applications 
needed to store and analyze molecular biology and genetic 
information. 
One of the signature projects of NCBI is GenBank, an anno-
tated online database of all publicly available DNA sequences.  
NCBI acts as a central repository for genetic sequence data, 
exchanging data with multiple international partners on a daily 
basis, collecting sequence information directly from research-
ers, and receiving data submitted to the U.S. Patent and Trade 
Office.  NCBI offers integrated search tools such as Entrez 
which searches NCBI’s vast collection of biomedical databas-
es and BLAST which allows researchers to find similar nuc-
leotide or protein sequences in sequence databases.  These 
tools link sequence information with related publications in 
databases such as PubMed thereby helping accelerate gene-
based discoveries and research. 
In addition to the funding activities already mentioned, the 
American Recovery and Reinvestment Act of 2009 allocated 
$1.1 billion for comparative effectiveness research.  Of these 
funds, $400 million has been directed to the Office of the Sec-
retary in HHS.  Comparative effectiveness research helps pro-
vide information on the benefits and drawbacks of different 
treatment options and offers much potential for informatics 
research.  Thus a significant portion of these funds will likely 
go to support informatics-related research.  The Federal Coor-
dinating Council for Comparative Effective Research tasked 
with prioritizing spending for these funds has recommended 
the primary investment be for data infrastructure.  As de-
scribed in the Council’s report to the President, “Data infra-
structure could include linking current data sources to enable 
answering CER questions, development of distributed elec-
tronic data networks and patient registries, and partnerships 
with the private sector” [21]. 
Many other federally-funded health care programs have also 
made important efforts to bring together useful data sets and 
analyze this data to improve health care.  For example, NIH 
has also created the National Electronic Clinical Trials and 
Research (NECTAR) network to share clinical research data 
between researchers and institutions.  Better access to clinical 
trial data will help eliminate duplication between different 
trials and help doctors find and apply the most effective treat-
ments.  CDC runs the National Electronic Disease Surveil-
lance System (NEDSS), a program to monitor public health 
for disease trends and outbreaks.  Using public health, labora-
tory and clinical data, each state implements its own electronic 
surveillance system for communicable disease surveillance, 
either using NEDSS or its own custom information system.  A 
recent survey found that 40 states have a fully-functional elec-
tronic surveillance system in use [13].  CDC also operates 
BioSense, a program designed to rapidly identify and monitor 
bioterrorism and disease outbreaks.  The FDA launched the 
Sentinel Initiative in 2008 with the goal of developing a sys-
tem to monitor the safety of drugs and other medical products 
regulated by the FDA.  While still in its early states, the goal 
of the Sentinel Initiative is to allow the FDA to query external 
databases—such as electronic health record systems, insurance 
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databases and other medical registries—and more rapidly 
detect potential threats. 
B. United Kingdom 
National-level funding for basic medical research in United 
Kingdom has historically come from two principal sources: 
the Medical Research Council (MRC) and the National Insti-
tute for Health Research (NIHR).  In 2006, in response to a 
report published by Sir David Cooksey, the British govern-
ment decided to recalibrate spending on medical research by 
creating the Office for Strategic Coordination of Health Re-
search (OSCHR).  The purpose of OSCHR is to better coordi-
nate funding for medical research at the national level to make 
research more effective, maximize the clinical benefits for 
patients, and better utilize limited resources.  Following the 
2007 Comprehensive Spending Review, the budgets of both 
departments were combined into a single research fund.  The 
last stage of consolidation occurred in 2008 when Scotland 
and Wales both decided to fully commit their share of finan-
cial resources to the research fund.  By 2010, total annual re-
search funding will be approximately £1.7 billion. 
As the October 2008 OSCHR report details, “The OSCHR 
Board has identified E-health records research, and particular-
ly the research potential of large electronic patient record da-
tabases, as a major opportunity for UK biomedical science, 
patient safety and public health” [15].  OSCHR has made a 
substantial financial commitment to health informatics in its 
planned budget for 2010-2011, the period at the end of the 
current three-year Comprehensive Spending Review.  Funding 
for this research will come both from MRC and NIHR 
sources.  The NIHR budget includes £18 million for the Re-
search Capabilities Programme of Connecting for Health in 
England.  The MRC budget includes £0.6 million to support 
collaborative programs that will study how to use electronic 
data sets to improve medical research [15]. 
The Research Capability Programme is part of the National 
Health Service (NHS), the publicly-funded health care system 
that serves all residents in the United Kingdom.  In 1998, the 
Department of Health created a national initiative, NHS Con-
necting for Health, to modernize its health care system 
through the use of IT.  The Research Capability Programme is 
an initiative of NHS Connecting for Health.  Originally con-
ceived in 2005 as an initiative to gather population data for 
epidemiological and comparative effectiveness studies, the 
mission of the program has evolved into a broad effort to 
transform the NHS so that health care research is a core area 
of focus.  The objective is to tap into the vast potential supply 
of NHS data for the purpose of improving health care quality 
and safety for patients through improved medical research. 
The Research Capability Programme was created in re-
sponse to a 2007 report from the UK Clinical Research Colla-
boration's (UKCRC) Advisory Group.  The UKCRC report 
identified six specific recommendations for the UK to improve 
its research capabilities.  These recommendations included:  
mandating the use of a unique identifier in all patient records; 
making research a core objective of the NHS Care Records 
Service; making available databases of complete, longitudinal 
medical records that cover the entire population; improving 
data completeness and data quality; addressing regulatory and 
governance issues regarding the use of data; engaging with all 
relevant stakeholders [18].  In direct response to the UKCRC 
report, the Research Capabilities Programme is currently de-
veloping the technical architecture, functional requirements, 
data standards, information governance, infrastructure, and 
stakeholder engagement needed to improve the UK’s clinical 
research capabilities. 
Outside of NHS, the United Kingdom has seven research 
councils that fund research in various fields.  Since 2001, all 
of the research councils have participated in the UK e-Science 
Programme, a coordinated effort to give researchers across all 
domains access to the large data sets, computing resources, 
and software tools need to exploit informatics research.  
Launched as a joint program between the research councils 
and the now defunct Department of Trade and Industry, the 
initiative received £118 million in initial funding.  It has expe-
rienced some notable successes, for example, using grid com-
puting to identify three drugs that can be used to treat antibiot-
ic-resistant bacterial infections.  Funding for the e-Science 
Programme also supported the development of CancerGrid, an 
initiative to develop software tools to reduce the cost of clini-
cal research and make data sharing more efficient. 
While most of the health informatics research funding 
comes from the MRC, for some of this research the MRC 
partners with other research councils including the Biotech-
nology and Biological Sciences Research Council (BBSRC), 
the Engineering and Physical Sciences Research Council 
(EPSRC) and the Economic and Social Research Council 
(ESRC).  For example in 2008, the BBSRC, which has an an-
nual budget of approximately £450 million, established a £6.5 
million bioinformatics and biological resources fund to sup-
port health informatics research. 
Past MRC activity has shown its commitment to health in-
formatics research in previous years through its funding and 
strategic decisions.  Between 2005 and 2006, MRC increased 
its funding for informatics fellowships from £0.9 to £1.4 mil-
lion.  In 2006, the MRC provided £1.1 million in funding to 
the National Cancer Research Institute bioinformatics initia-
tive.  In 2007, the MRC granted funds totaling £2.2 million to 
support workforce development in bioinformatics.  In 2008, 
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the MRC allocated £1.5 million to award grants supporting the 
use of electronic databases for medical research.  EPSRC, 
ESRC and the Wellcome Trust contributed additional funds to 
this project resulting in a total funding of £10 million.  MRC 
also worked with EPSRC to jointly fund a £2.3 million initia-
tive to study how information systems can be used to drive 
better quality diagnosis and treatments in health care [17].   
The MRC has set out a new strategic plan for 2009 to 2014 
that continues to emphasize health informatics research.  This 
plan includes four strategic goals, one of which includes the 
objective of fully exploiting the potential benefits of popula-
tion-based data by developing tools to use existing data sets, 
sharing and linking future data sets, and developing a national 
framework to support this type of research. 
Various nongovernmental organizations in the United 
Kingdom also focus on health informatics and operate, at least 
in part, with public funding.  For example, the European Bio-
informatics Institute (EBI) at Cambridge is one of the primary 
sites for biomedical informatics research in the United King-
dom.  EBI is one of the five centers of the European Molecular 
Biology Laboratory (EMBL), a major basic research institute 
supported by public funds from 20 European nations.  In addi-
tion to providing free public access to online biological data-
bases, EBI pursues bioinformatics research and offers bioin-
formatics training to students and scientists.  In 2008, EBI 
operated with a budget of approximately €43.2 million with 
approximately 45 percent of the budget from EMBL.  EBI 
receives additional funding from various sources, including 
close to €3 million from the NIH in the United States and a 
similar combined amount from two of the research councils 
(MRC and BBSRC) in the United Kingdom.  The remaining 
funds for EBI come from the European Commission (€8.8 
million) and the Wellcome Trust (€7.5 million).  The Well-
come Trust is the largest charity in the United Kingdom, 
spending approximately £600 million annually on research 
domestically and abroad. 
Another important nongovernmental organization contribut-
ing to this research is the National Cancer Research Institute 
(NCRI).  NCRI is a public-private partnership between various 
stakeholders supporting cancer research in the United King-
dom.  NCRI began the Informatics Initiative in 2003 with the 
goal of maximizing the impact of cancer research through the 
application of informatics.  It has focused on improving data 
sharing within the cancer research community by developing 
internationally-accepted data standards, databases, and data 
tools.  The primary interface to this data is the NCRI Oncolo-
gy Information Exchange (ONIX).  ONIX is a portal to vari-
ous data sources and provides researchers specialized tools to 
search biomedical databases. 
One of NCRI’s key accomplishments is promoting data 
sharing of all publicly funded research both through creating 
technical standards and enacting cultural change in the re-
search community.  The MRC has been one of the leading 
partners in this effort having established a data sharing initia-
tive in 2001.  Other cancer research partners, including the 
Wellcome Trust, BBSRC, and Cancer Research UK have fol-
lowed with their own policies to support better data sharing.  
For example, in April 2007, BBSRC established a new data 
sharing policy that states that it will fund efforts to make data 
available with as few restrictions as possible for further scien-
tific use by its researchers. 
IV.  RECOMMENDATIONS AND CONCLUSIONS 
Both the United States and the United Kingdom make sig-
nificant investments in medical research.  Thus it is little sur-
prise that both nations have made investments in informatics 
research as its importance to medical research continues to 
grow.  The total public investment by the United States in 
health informatics is substantially greater than in the United 
Kingdom.  However, both countries commit roughly the same 
percentage of total public medical research funds to health 
informatics.  Because this report has only looked at publicly-
funded research, it cannot be used to infer which country pos-
sesses more technical capacity for biomedical informatics re-
search. 
Qualitative differences exist between the approaches taken 
by these two nations on health informatics.  An important de-
velopment in the United Kingdom has been the creation of the 
Research Capability Programme.  The United Kingdom is 
uniquely positioned to benefit from advancements in health 
informatics research because it is significantly ahead of the 
United States in its transition to electronic health records 
among primary care providers.  More importantly, NHS has 
made an important strategic decision to emphasize medical 
research as a core activity that it must support.  Thus, as NHS 
continues to develop its IT infrastructure, it will be able to 
make technical upgrades to improve information sharing and 
its information base for research.  Moreover, because of its 
unique role, NHS can more directly impact issues critical to 
researchers such as improving data quality through its own 
policy directives. 
Researchers in the United Kingdom can take advantage of 
the national electronic health record system with projects like 
UK Biobank.  UK Biobank is a large-scale medical research 
project to study how an individual’s health is affected by life-
style, environment and genes.  Using both public and private 
funds, the project intends to enroll 500,000 participants in the 
United Kingdom who will participate in an initial health as-
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sessment, provide medical samples and consent to allow re-
searchers to monitor their medical records indefinitely.  This 
project is made possible by the data sharing capabilities of 
NHS that will allow researchers to track the health of partici-
pants over the next few decades.  Even initiating the project 
required NHS data—NHS medical records were used to iden-
tify potential participants and invite them to join the study 
[20]. 
The United States currently lacks the capacity being devel-
oped by the NHS to turn its existing or future electronic health 
records into a usable database for medical research.  This is 
not too surprising given the decentralized approach of the cur-
rent efforts to increase adoption of electronic health record 
systems.  In the United States, the closest alternative to the 
information base the NHS is building is the HMO research 
network, a consortium of 16 health maintenance organizations 
(HMO) in the United States that provide researchers access to 
health data for a large population.   
To address this deficiency, future efforts in the United 
States to speed adoption of electronic health records systems 
should include functional requirements to allow the second-
ary-use of medical data for research.  For example, HHS 
should consider the importance of secondary use of medical 
data as it develops interoperability requirements and other 
standards in its evolving definition of “meaningful use” that 
will determine how funds are spent from the 2009 stimulus 
package.  The goal should be to develop a national data-
sharing infrastructure to support health informatics research, 
rather than to create isolated, project-specific research data-
bases.  Many current or proposed projects focus on adding an 
additional layer of reporting requirements to health care pro-
viders to gain access to important patient data rather than 
simply making all patient data accessible for research.  For 
example, Rep. Dingell (D-MI) recently introduced the “Amer-
ica's Affordable Health Choices Act of 2009” (H.R. 3200) 
which included a provision that all health care centers receiv-
ing federal dollars from Medicare or Medicaid programs be 
required to report hospital-acquired infections to CDC’s Na-
tional Healthcare Safety Network [10]. 
Challenges remain for both nations, especially in regards to 
data sharing.  Continued funding is necessary to develop the 
technical infrastructure and data standards needed to improve 
data sharing between existing systems.  In addition, a mechan-
ism is needed to allow relevant medical data to be shared for 
authorized medical research in a timely and efficient manner.  
Safeguards must be put in place to protect patient privacy, but 
these individual protections must be balanced against the po-
tential benefits from research.  As Reference [9] has shown, 
privacy regulations can have a substantial impact on technolo-
gy diffusion.  As a result, policymakers should be cautious of 
implementing privacy regulations that impede technology 
adoption in health care, as it could have a significant impact 
on health care quality and medical research. 
The United Kingdom appears more prepared to address 
these challenges.  As part of its Information Governance and 
Threat Assessment agenda, the Research Capabilities Pro-
gramme has produced work documents that address many of 
these issues relating to data sharing.  For example, it has iden-
tified options and next steps to develop a pseudonymization 
service for the de-identification of patient data, and it has ana-
lyzed the legal issues that need to be clarified in the United 
Kingdom to use patient data for research.  Issues such as pa-
tient consent must be resolved before data from electronic 
health records can be used extensively for medical research.  
Patient consent may be required to either use patient medical 
data directly in research studies or to identify patients for po-
tential inclusion in research studies.   
The United States should also form a comprehensive review 
of these data- sharing challenges.  For example, it should con-
sider the current legal framework for sharing research data.  
Like the MRC, the NIH has made a clear commitment to data 
sharing.  As of October 2003, NIH has required that all grant 
applicants seeking funds of $500,000 or more include a data 
sharing plan as part of the proposal or explain why data shar-
ing is not possible.  However, NIH has acknowledged that 
state and federal laws, including the HIPAA Privacy Rule, 
may interfere with data sharing [16]. 
Finally, both nations need to ensure they have strong re-
search communities.  Advanced biomedical informatics re-
search will not only require having the technical infrastructure 
in place, it will also require having a talented pool of research-
ers trained in biomedical informatics and related fields.  In the 
United Kingdom, the MRC has funded workforce training and 
fellowships.  In the United States, the NCBC has been used to 
expand the population of trained researchers in biomedical 
informatics, bioinformatics and computational biology [14].  
In addition, both the United States and the United Kingdom 
recognize the need to work collaboratively on this research 
and partner with the private sector.  As previously discussed, 
research communities in both countries have formed working 
partnerships, such as the collaboration seen between the NCI 
and the NCRI. 
The need for pursuing informatics in health care has been 
recognized at the local, national and international levels.  In 
2005, the World Health Organization adopted Resolution 
WHA58.28 to establish an eHealth Strategy that noted the 
“potential impact that advances in information and communi-
cation technologies” could have on medical research and 
urged member states to implement “national electronic public-
health information systems and to improve, by means of in-
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formation, the capacity for surveillance of, and rapid response 
to, disease and public-health emergencies” [8].  Both the Unit-
ed States and the United Kingdom have responded to this call, 
and both have made substantial commitments to continue to 
improve the use of IT in medical research in the following 
years. 
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